| Product Type | Impurity Standards |
| CAT. No. | MRL-C65007 |
| CAS. No. | 134862-11-6 |
| Mol. Formula | C14H19Cl2NO2 |
| Mol. Weight | 304.21 |
| Chemical Name | 3-[Bis(2-chloroethyl)amino]benzenebutanoicAcid |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | Custom Synthesis |
Meta Chlorambucil with CAS No: 134862-11-6 is an impurity standard of Chlorambucil. Chlorambucil is an alkylating agent and a chemotherapy medication used in the treatment of various cancers, particularly certain types of leukemia, lymphoma, and other malignancies. As an alkylating agent, chlorambucil interferes with the DNA structure of cancer cells, preventing their replication and growth. It is commonly prescribed for chronic lymphocytic leukemia (CLL) and certain types of non-Hodgkin lymphomas. Chlorambucil is administered orally in the form of tablets. Due to its potential for side effects and toxicities, including bone marrow suppression, patients undergoing treatment with chlorambucil are carefully monitored, and the dosage may be adjusted based on individual response and tolerance. As with any chemotherapy drug, the decision to use chlorambucil is made by healthcare professionals after considering the specific type and stage of cancer and the patients overall health. Buy high quality Meta Chlorambucil from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of Meta Chlorambucil